JP2005508936A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005508936A5 JP2005508936A5 JP2003533847A JP2003533847A JP2005508936A5 JP 2005508936 A5 JP2005508936 A5 JP 2005508936A5 JP 2003533847 A JP2003533847 A JP 2003533847A JP 2003533847 A JP2003533847 A JP 2003533847A JP 2005508936 A5 JP2005508936 A5 JP 2005508936A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- skin
- salicylate
- phytosphingosine
- hinokitiol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 14
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 claims 12
- 229960001860 salicylate Drugs 0.000 claims 7
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 claims 7
- 230000000699 topical effect Effects 0.000 claims 7
- AERBNCYCJBRYDG-UHFFFAOYSA-N D-ribo-phytosphingosine Natural products CCCCCCCCCCCCCCC(O)C(O)C(N)CO AERBNCYCJBRYDG-UHFFFAOYSA-N 0.000 claims 6
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 claims 6
- 150000004676 glycans Chemical class 0.000 claims 6
- AERBNCYCJBRYDG-KSZLIROESA-N phytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@@H](N)CO AERBNCYCJBRYDG-KSZLIROESA-N 0.000 claims 6
- 229940033329 phytosphingosine Drugs 0.000 claims 6
- 229920001282 polysaccharide Polymers 0.000 claims 6
- 239000005017 polysaccharide Substances 0.000 claims 6
- 201000004700 rosacea Diseases 0.000 claims 6
- 229930007845 β-thujaplicin Natural products 0.000 claims 6
- 241000124001 Alcyonacea Species 0.000 claims 5
- 241001303601 Rosacea Species 0.000 claims 5
- 244000269722 Thea sinensis Species 0.000 claims 5
- 239000003963 antioxidant agent Substances 0.000 claims 5
- 230000003078 antioxidant effect Effects 0.000 claims 5
- 235000009569 green tea Nutrition 0.000 claims 5
- 239000004615 ingredient Substances 0.000 claims 5
- 239000002085 irritant Substances 0.000 claims 5
- 150000004492 retinoid derivatives Chemical class 0.000 claims 5
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims 4
- 241000283707 Capra Species 0.000 claims 3
- 230000001575 pathological effect Effects 0.000 claims 3
- 206010043189 Telangiectasia Diseases 0.000 claims 2
- 230000000844 anti-bacterial effect Effects 0.000 claims 2
- 230000000845 anti-microbial effect Effects 0.000 claims 2
- 239000004599 antimicrobial Substances 0.000 claims 2
- 239000002537 cosmetic Substances 0.000 claims 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 229960004889 salicylic acid Drugs 0.000 claims 2
- 208000009056 telangiectasis Diseases 0.000 claims 2
- 235000014653 Carica parviflora Nutrition 0.000 claims 1
- 241000243321 Cnidaria Species 0.000 claims 1
- 230000007794 irritation Effects 0.000 claims 1
- 150000003902 salicylic acid esters Chemical class 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/971,561 US6680062B2 (en) | 2001-10-05 | 2001-10-05 | Anti-irritating rosacea treatment |
| PCT/US2002/029722 WO2003030813A2 (en) | 2001-10-05 | 2002-09-18 | Anti-irritating rosacea treatment |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006225842A Division JP2006306899A (ja) | 2001-10-05 | 2006-08-22 | 抗刺激性酒さ治療 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005508936A JP2005508936A (ja) | 2005-04-07 |
| JP2005508936A5 true JP2005508936A5 (enExample) | 2006-01-05 |
| JP3921202B2 JP3921202B2 (ja) | 2007-05-30 |
Family
ID=25518547
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003533847A Expired - Fee Related JP3921202B2 (ja) | 2001-10-05 | 2002-09-18 | 抗刺激性酒さ治療 |
| JP2006225842A Pending JP2006306899A (ja) | 2001-10-05 | 2006-08-22 | 抗刺激性酒さ治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006225842A Pending JP2006306899A (ja) | 2001-10-05 | 2006-08-22 | 抗刺激性酒さ治療 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6680062B2 (enExample) |
| EP (1) | EP1441685B1 (enExample) |
| JP (2) | JP3921202B2 (enExample) |
| AT (1) | ATE414527T1 (enExample) |
| AU (1) | AU2002334601B2 (enExample) |
| CA (1) | CA2461941C (enExample) |
| DE (1) | DE60229971D1 (enExample) |
| ES (1) | ES2316647T3 (enExample) |
| WO (1) | WO2003030813A2 (enExample) |
Families Citing this family (61)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7314634B2 (en) * | 2002-02-22 | 2008-01-01 | Steven Hernandez | Use of polyphenols to treat skin conditions |
| US7851477B2 (en) * | 2003-05-22 | 2010-12-14 | L'oreal | Method for the treatment of skin |
| US8410102B2 (en) | 2003-05-27 | 2013-04-02 | Galderma Laboratories Inc. | Methods and compositions for treating or preventing erythema |
| US7439241B2 (en) | 2003-05-27 | 2008-10-21 | Galderma Laboratories, Inc. | Compounds, formulations, and methods for treating or preventing rosacea |
| US20050020600A1 (en) | 2003-07-23 | 2005-01-27 | Scherer Warren J. | Methods of treating cutaneous flushing using selective alpha-2-adrenergic receptor agonists |
| WO2005048929A2 (en) * | 2003-11-13 | 2005-06-02 | Galileo Pharmaceuticals, Inc. | Plant-derived protein extract compositions and methods |
| CA2552607C (en) * | 2004-01-07 | 2012-04-17 | E-L Management Corporation | Cosmetic composition and method for retarding hair growth |
| US7812049B2 (en) * | 2004-01-22 | 2010-10-12 | Vicept Therapeutics, Inc. | Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using α1-adrenoceptor agonists |
| AU2005203301A1 (en) * | 2004-07-30 | 2006-02-16 | Johnson & Johnson Consumer Companies, Inc. | Compositions and methods for treating skin conditions |
| DE102005005486A1 (de) * | 2005-02-04 | 2006-08-17 | Schwan-Stabilo Cosmetics Gmbh & Co. Kg | Zubereitung, insbesondere kosmetische Zubereitung sowie ihre Herstellung und Verwendung |
| EP1898952B1 (en) | 2005-06-17 | 2012-09-12 | Symrise AG | Synergistic mixtures of aromatic alcohols and derivatives thereof with tropolone |
| FR2894821B1 (fr) * | 2005-12-15 | 2008-02-29 | Galderma Res & Dev | Compositions comprenant au moins un compose retinoide et au moins un compose anti-irritant et leurs utilisations |
| US20090274736A1 (en) * | 2006-01-19 | 2009-11-05 | Solazyme Inc. | Nutraceutical Compositions From Microalgae And Related Methods of Production And Administration |
| US20070166266A1 (en) * | 2006-01-19 | 2007-07-19 | Solazyme, Inc. | Methods and compositions for improving the health and appearance of skin |
| US20070191303A1 (en) * | 2006-01-19 | 2007-08-16 | Solazyme, Inc. | Polysaccharide compositions and methods of producing, screening, and formulating polysaccharide compositions |
| US8298548B2 (en) | 2007-07-18 | 2012-10-30 | Solazyme, Inc. | Compositions for improving the health and appearance of skin |
| WO2007136428A2 (en) * | 2006-01-19 | 2007-11-29 | Solazyme, Inc. | Nutraceutical compositions from microalgae and related methods of production and administration |
| US8277849B2 (en) * | 2006-01-19 | 2012-10-02 | Solazyme, Inc. | Microalgae-derived compositions for improving the health and appearance of skin |
| US7381433B1 (en) * | 2007-01-08 | 2008-06-03 | Johnson & Johnson Consumer Companies, Inc. | Compositions containing an extract of a primula denticulata and use thereof |
| CA2749750C (en) * | 2008-04-15 | 2014-01-28 | Immanence Integrale Dermo Correction Inc. | Skin care compositions and methods of use thereof |
| EP2116237A1 (en) * | 2008-08-05 | 2009-11-11 | Polichem SA | Compositions for treating rosacea comprising chitosan and a dicarboxylic acid |
| US8927522B2 (en) | 2008-10-14 | 2015-01-06 | Solazyme, Inc. | Microalgal polysaccharide compositions |
| US8557249B2 (en) | 2008-11-07 | 2013-10-15 | Solazyme, Inc. | Cosmetic compositions comprising microalgal components |
| EP2329849B1 (en) | 2009-11-18 | 2015-04-29 | Galderma Research & Development | Combination of alpha-2 adrenergic receptor agonist and non-steroidal anti-inflammatory agent for treating or preventing an inflammatory skin disorder |
| US8394800B2 (en) * | 2009-11-19 | 2013-03-12 | Galderma Laboratories, L.P. | Method for treating psoriasis |
| JP2013521300A (ja) * | 2010-03-03 | 2013-06-10 | ネオキュティス エスアー | 抗菌ペプチド隔離化合物を用いた皮膚疾患および皮膚障害の処置のための組成物および方法 |
| US9180112B2 (en) * | 2010-03-23 | 2015-11-10 | Ermis Labs, LLC | Dermal compositions containing gorgonian extract |
| CN103298472A (zh) | 2010-03-26 | 2013-09-11 | 盖尔德马研究及发展公司 | 安全和有效治疗红斑的改进的方法和组合物 |
| WO2011117378A2 (en) | 2010-03-26 | 2011-09-29 | Galderma Research & Development | Improved methods and compositions for safe and effective treatment of telangiectasia |
| ES2498217T5 (es) | 2010-10-21 | 2018-03-19 | Galderma S.A. | Composición en forma de gel basada en brimonidina |
| US8053427B1 (en) | 2010-10-21 | 2011-11-08 | Galderma R&D SNC | Brimonidine gel composition |
| CN106176361A (zh) | 2010-12-30 | 2016-12-07 | 玫琳凯有限公司 | 局部皮肤用组合物及其用途 |
| US11279674B2 (en) | 2011-01-03 | 2022-03-22 | The William M. Yarbrough Foundation | Isothiocyanate functional surfactant and associated method of use |
| US9962361B2 (en) | 2011-01-03 | 2018-05-08 | The William M. Yarbrough Foundation | Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use |
| US11407713B2 (en) | 2011-01-03 | 2022-08-09 | The William M. Yarbrough Foundation | Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use |
| US8933119B2 (en) | 2011-01-03 | 2015-01-13 | The William M. Yarbrough Foundation | Method for treating phytophotodermatitis |
| US10273205B2 (en) | 2011-01-03 | 2019-04-30 | The William M. Yarbrough Foundation | Isothiocyanate functional surfactants, formulations incorporating isothiocyanate functional surfactants and associated methods for treating biofilms |
| US10640464B2 (en) | 2011-01-03 | 2020-05-05 | The William M. Yarbrough Foundation | Use of isothiocyanate functional surfactants as Nrf2 inducers to treat epidermolysis bullosa simplex and related diseases |
| US10647668B2 (en) | 2011-01-03 | 2020-05-12 | The William M. Yarbrough Foundation | Isothiocyanate functional surfactant and associated method of use |
| US10308599B2 (en) | 2011-01-03 | 2019-06-04 | The William M. Yarbrough Foundation | Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use |
| US8865765B2 (en) | 2011-01-12 | 2014-10-21 | The William M. Yarbrough Foundation | Method for treating eczema |
| US9532969B2 (en) | 2011-02-08 | 2017-01-03 | The William M. Yarbrough Foundation | Method for treating psoriasis |
| WO2013016072A1 (en) | 2011-07-22 | 2013-01-31 | Allergan, Inc. | Pharmaceutical compositions comprising 4-bromo-n-(imidazolidin-2-ylidene)-1h-benzimidazol-5-amine for treating skin diseases |
| WO2013057579A2 (en) | 2011-10-19 | 2013-04-25 | Galderma Pharma S.A. | Method of reducing facial flushing associated with systemic use of phosphodiesterase type 5 inhibitors |
| US9283217B2 (en) | 2011-11-10 | 2016-03-15 | Allergan, Inc. | Pharmaceutical compositions comprising 7-(1 H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions |
| UA109359C2 (xx) | 2011-11-10 | 2015-08-10 | Лікування захворювань і станів шкіри 7-(1h-імідазол-4-ілметил)-5,6,7,8-тетрагідрохіноліном | |
| US8877259B2 (en) | 2012-02-09 | 2014-11-04 | Mary Kay Inc. | Cosmetic formulation |
| US9839621B2 (en) | 2012-07-26 | 2017-12-12 | The William M. Yarbrough Foundation | Method for treating bladder cancer |
| US10080734B2 (en) | 2012-07-26 | 2018-09-25 | The William M. Yarbrough Foundation | Method for treating autism and other neurodevelopmental disorders |
| US10335387B2 (en) | 2012-07-26 | 2019-07-02 | The William M. Yarbrough Foundation | Method for treating infectious diseases with isothiocyanate functional compounds |
| US10434081B2 (en) | 2012-07-26 | 2019-10-08 | The William M. Yarbrough Foundation | Inhibitors of macrophage migration inhibitory factor |
| US9949943B2 (en) * | 2012-07-26 | 2018-04-24 | The William M. Yarbrough Foundation | Method for treating neurodegenerative diseases |
| US10441561B2 (en) | 2012-07-26 | 2019-10-15 | The William M. Yanbrough Foundation | Method for treating benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer |
| US10434082B2 (en) | 2012-07-26 | 2019-10-08 | The William M. Yarbrough Foundation | Isothiocyanate functional compounds augmented with secondary antineoplastic medicaments and associated methods for treating neoplasms |
| US8865772B2 (en) | 2012-07-26 | 2014-10-21 | The William M. Yarbrough Foundation | Method for treating skin cancer |
| US9861645B2 (en) | 2012-12-28 | 2018-01-09 | Rak Holdings Llc | Anti-itch scalp treatment compositions and combinations |
| BR112015028457A8 (pt) | 2013-05-15 | 2017-10-03 | Solazyme Inc | Composições cosméticas compreendendo óleo de microalgas |
| EP3166590B1 (en) | 2014-07-11 | 2020-07-08 | Mary Kay Inc. | Pore minimizer |
| GB2528482A (en) * | 2014-07-23 | 2016-01-27 | Skintech Life Science Ltd | Pharmaceutical agent |
| PY1917053A (es) * | 2018-03-09 | 2019-09-13 | Ocusoft Inc | Composiciones tópicas para el cuidado de la piel |
| WO2025245187A1 (en) | 2024-05-22 | 2025-11-27 | Blue Evolution Inc. | Composition of and method of extraction of ulva gel from seaweed polysaccharide and protein |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1332650C (en) | 1987-06-18 | 1994-10-18 | Kunitaka Hirose | Polysaccharides and antiviral drugs containing the same as active ingredient |
| US5306486A (en) | 1993-03-01 | 1994-04-26 | Elizabeth Arden Co., Division Of Conopco, Inc. | Cosmetic sunscreen composition containing green tea and a sunscreen |
| FR2732221B1 (fr) | 1995-03-28 | 1997-04-25 | Oreal | Utilisation d'un antagoniste de cgrp pour traiter les rougeurs cutanees d'origine neurogene et composition obtenue |
| US5624911A (en) | 1995-06-07 | 1997-04-29 | The Regents Of The University Of California | Ether derivatives of pseudopterosin |
| IL114267A0 (en) | 1995-06-22 | 1995-10-31 | Univ Ben Gurion | Antiviral agents |
| US5792794A (en) | 1995-09-01 | 1998-08-11 | Gist-Brocades, N.V. | Retinoylamide based derivatives of sphingoid bases |
| US5885595A (en) | 1996-05-13 | 1999-03-23 | Elizabeth Arden Co., Division Of Conopco, Inc. | Cosmetic composition with a retinol fatty acid ester |
| US5811114A (en) | 1996-06-12 | 1998-09-22 | E-L Management Corp. | Stabilized hinokitiol and compositions containing same |
| US5728732A (en) | 1996-11-27 | 1998-03-17 | Elizabeth Arden Company, Division Of Conopco, Inc. | Skin treatment with salicylic acid esters and retinoids |
| CA2302561C (en) * | 1997-09-12 | 2006-02-14 | The Procter & Gamble Company | Cleansing and conditioning article for skin or hair |
| CN1112916C (zh) | 1997-12-05 | 2003-07-02 | 科斯莫弗姆有限公司 | 含有游离类鞘氨醇碱和神经酰胺组合的组合物及其用途 |
| US5972993A (en) | 1998-03-20 | 1999-10-26 | Avon Products, Inc. | Composition and method for treating rosacea and sensitive skin with free radical scavengers |
| EP1093525A1 (en) | 1998-07-03 | 2001-04-25 | Cosmoferm B.V. | Improved microbial strains producing sphingoid bases |
| US5952372A (en) | 1998-09-17 | 1999-09-14 | Mcdaniel; William Robert | Method for treating rosacea using oral or topical ivermectin |
-
2001
- 2001-10-05 US US09/971,561 patent/US6680062B2/en not_active Expired - Lifetime
-
2002
- 2002-09-18 DE DE60229971T patent/DE60229971D1/de not_active Expired - Lifetime
- 2002-09-18 EP EP02800840A patent/EP1441685B1/en not_active Expired - Lifetime
- 2002-09-18 CA CA2461941A patent/CA2461941C/en not_active Expired - Fee Related
- 2002-09-18 WO PCT/US2002/029722 patent/WO2003030813A2/en not_active Ceased
- 2002-09-18 AU AU2002334601A patent/AU2002334601B2/en not_active Ceased
- 2002-09-18 ES ES02800840T patent/ES2316647T3/es not_active Expired - Lifetime
- 2002-09-18 JP JP2003533847A patent/JP3921202B2/ja not_active Expired - Fee Related
- 2002-09-18 AT AT02800840T patent/ATE414527T1/de not_active IP Right Cessation
-
2006
- 2006-08-22 JP JP2006225842A patent/JP2006306899A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2461941A1 (en) | Anti-irritating rosacea treatment | |
| ATE401089T1 (de) | Orale zubereitungen, die antimikrobielle wirkstoffe enthalten zur prävention von systemischen erkrankungen | |
| WO2019199861A3 (en) | Hemp extract for treatment of pain in animals | |
| EP2961418B1 (en) | Acne solution | |
| WO2004093569A1 (en) | Topical composition on the basis of honey | |
| JP2011522831A (ja) | ナノシルバーを含むニキビ治療用組成物及びその使用 | |
| CA2600384A1 (en) | Compositions and methods for treating acne | |
| CN110035797B (zh) | 用于治疗痤疮的具有益生元特性的协同草药组合物 | |
| DE60229431D1 (de) | Verwendungen von chitosanoligosacchariden | |
| JP2002526407A5 (enExample) | ||
| WO2007102090A3 (en) | Topical formulation | |
| WO2011104900A1 (ja) | 抗真菌剤 | |
| JP2005507903A5 (enExample) | ||
| US10071052B2 (en) | Method for the prevention and treatment of acne | |
| CN105749331A (zh) | 一种香紫苏伤口敷料及其制备方法 | |
| JP2008543902A5 (enExample) | ||
| CN103623152A (zh) | 一种祛痘、去痘印、祛除痤疮疤痕的药 | |
| JP2024516316A5 (enExample) | ||
| EP2588095B1 (en) | Composition for the treatment of acne vulgaris | |
| CA2489705A1 (en) | Use of amide derivative of ge 2270 factor a3 for the treatment of acne | |
| PH12022551384A1 (en) | Chronic wound healing composition and application thereof | |
| CN105030639B (zh) | 一种拔毒祛痘膏及其制备方法 | |
| KR20060021775A (ko) | 애완동물의 탈모, 모발손상, 피부 질환을 예방 및치료하는 애완동물용 모발 트리트먼트 및 입욕 보조제 | |
| US20240207345A1 (en) | Methods and compositions for treating hair loss | |
| JP2026506380A (ja) | 皮膚の状態または疾患を処置する方法 |